Results 161 to 170 of about 56,879 (236)

Low‐Dose Mavacamten Initiation in Obstructive Hypertrophic Cardiomyopathy: A Real‐World Study in China

Cardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Aims To evaluate the real‐world efficacy and safety of low‐dose (2.5 mg) mavacamten initiation in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Methods and Results This single‐center observational study (Zhongshan Hospital, China; Oct 2024–Apr 2025) enrolled 72 symptomatic oHCM patients (NYHA II/III, LVEF ≥ 55 ...
Wenlong Yang, Hui Shi, Rebecca Suchi Chang, Yin Zhang, A. Jixiang, Chunyu Wu, Juying Qian, Junbo Ge, Shuning Zhang, Baohui Xu   +9 more
wiley   +1 more source

A Contemporary Guide of Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock. [PDF]

J Cardiovasc Dev Dis
Chau VQ, Kalapurakal G, Imamura T, Chung BB, Loberg S, Beckett A, Tatooles AJ, Narang N.   +7 more
europepmc   +1 more source

Cardiac Arrest in a Pregnant Patient With Probable Spontaneous Coronary Artery Dissection and the Use of Targeted Temperature Management

Case Reports in Critical Care, Volume 2026, Issue 1, 2026.
Pregnancy‐associated spontaneous coronary artery dissection (SCAD) is a devastating cause of myocardial infarction that can lead to maternal and fetal demise. The use of targeted temperature management in a pregnant population post‐cardiac arrest is unclear given their exclusion from previous trials.
Stephanie Sibley, Paul Malik, Daniel Howes, Lipi Buch   +3 more
wiley   +1 more source

Rationale and design of the REMECHOQUE multicentre registry protocol: evaluating therapeutic trends in cardiogenic shock. [PDF]

BMJ Open
Jimenez-Franco V, Rodriguez Rivera J, Jerjes-Sanchez C, Castillo Perez M, Flores Zertuche M, De La Peña E, Torre-Amione G, Peña-Blade AG, Quevedo-Salazar R, Odin De Los Ríos M, Arias-Mendoza A, Magaña Serrano JA, Rojas Velasco G, Antezana J, Macedo L, Luis Leiva-Pons J.   +15 more
europepmc   +1 more source

Early initiation of guideline-directed medical therapy in patients with cardiogenic shock supported with Impella®: a two-center retrospective study

Yokawa, Junichiro, Nishikawa, Tetsuo, Shimojima, Masaya, Nakamura, Miho, Amino, Yuma, Sato, Koji, Koshida, Yoshinao, Taniguchi, Takumi   +7 more
openalex   +1 more source

Cardiogenic Shock in Hypertrophic Cardiomyopathy Treated With Mavacamten and Clarithromycin. [PDF]

JACC Case Rep
Alabdaljabar MS, Desai M, Geske JB.
europepmc   +1 more source

Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis

Hendrianus Hendrianus, Jeong Young-Hoon, Sang Yeub Lee, Jun Hwan Cho, Jinhwan Jo, Diana A. Gorog, Jacek Kubica, U. Tantry, Paul A. Gurbel, Sang-Wook Kim   +9 more
openalex   +1 more source

Hope in Miniature: The First Case of Implantation of a “Tiny Pacemaker” in Italy as a Successful Treatment for Congenital Atrioventricular Block in a Low Birth Weight Child

Case Reports in Cardiology, Volume 2026, Issue 1, 2026.
Congenital complete atrioventricular block (CAVB) is a rare cardiac condition occurring in approximately one in 15,000 to one in 22,000 live births. Maternal autoimmune diseases, with anti‐ssA (Ro) and anti‐ssB (La) antibodies implicated in 56%–90% of cases, are primary causes.
Ferrari Paola, Limonta Raul, Malanchini Giovanni, Patanè Luisa, De Filippo Paolo, Karuna Sharma   +5 more
wiley   +1 more source

Prediction of Cardiogenic Shock in Acute Myocardial Infarction Patients Using a Nomogram. [PDF]

J Clin Med
Wang J, Zhao C, Yang C, Dong Y, Yang X, Sun C.   +5 more
europepmc   +1 more source

Cardiac injury as a rare cause of cardiogenic shock following polytrauma

, 2014
Elena Marras, Sonja Cukon-Buttignoni, Giuseppe Berton, Wadih Tamari   +3 more
openalex   +1 more source